This session will provide a major update regarding our understanding of T-Cell biology, with a translational focus on T-Cell engineering and the use of these clinical tools in personalized medicine. Topics will include the biology of T-Cells with a focus on the 'translatable' aspects of working with T-Cells in personalized medicine, harnessing targeted T-Cell killing of lymphoma using CAR-T-Cells and the state-of-the-art for viral-specific T-Cells and their use in specific populations including transplant and immunodeficiency patients.
Upon completion of this activity, participants should be able to:
- Discuss the T-Cell features amenable to engineering/personalized medicine
- Discuss the latest advances in CAR-T-Cells used in the treatment of lymphoma
- Discuss viral specific T-Cells and their use in specific populations